Nasdaq Ckpt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ckpt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ckpt Today - Breaking & Trending Today

James F. Oliviero III Sells 11,900 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Stock

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT – Get Free Report) CEO James F. Oliviero III sold 11,900 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $2.01, for a total value of $23,919.00. Following the sale, the chief executive officer now directly owns 369,680 shares […] ....

United States , Checkpoint Therapeutics Company Profile , America Corp , Renaissance Technologies , Asset Group Inc , Sabby Management , Checkpoint Therapeutics Inc , Armistice Capital , Checkpoint Therapeutics , Get Free Report , Asset Group , Checkpoint Therapeutics Daily , Nasdaq Ckpt , Insider Trading , Nsider Trades ,

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Sees Large Growth in Short Interest

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT – Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 1,810,000 shares, an increase of 17.5% from the September 15th total of 1,540,000 shares. Based on an average trading volume of 290,400 shares, […] ....

Checkpoint Therapeutics Inc , Checkpoint Therapeutics Company Profile , Meitav Investment House Ltd , Eqis Capital Management Inc , Tower Research Capital , Cantor Fitzgerald , Checkpoint Therapeutics , Get Free Report , Investment House , Research Capital , Eqis Capital Management , Lake Street Capital , Checkpoint Therapeutics Daily , Nasdaq Ckpt ,

Checkpoint Therapeutics (CKPT) Set to Announce Quarterly Earnings on Monday

Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) will announce its Q2 2023 earnings results on Monday, August 21st. Analysts expect the company to announce earnings of ($0.83) per share and revenue of $0.02 million for the quarter. Checkpoint Therapeutics Stock Performance NASDAQ:CKPT traded up $0.25 during mid-day trading on Friday, hitting $2.22. 651,002 shares of […] ....

Cantor Fitzgerald , Osaic Holdings Inc , Blackrock Inc , Checkpoint Therapeutics Inc , Envestnet Asset Management Inc , Geode Capital Management , B Riley Wealth Advisors Inc , Checkpoint Therapeutics , Get Free Report , Capital Management , Asset Management , Wealth Advisors , Riley Wealth Advisors , Street Capital , Checkpoint Therapeutics Daily , Nasdaq Ckpt ,

Checkpoint Therapeutics (NASDAQ:CKPT) Stock Rating Reaffirmed by HC Wainwright

Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Friday, Benzinga reports. They currently have a $34.00 price target on the stock. Other research analysts have also issued reports about the stock. Lake Street Capital decreased their price target on […] ....

United States , Cantor Fitzgerald , America Corp , Armistice Capital , Asset Group Inc , Checkpoint Therapeutics Inc , Renaissance Technologies , Checkpoint Therapeutics , Get Free Report , Street Capital , Asset Group , Checkpoint Therapeutics Daily , Nasdaq Ckpt , Reiterated Rating , Hc Wainwright ,